Patent: 5,382,658
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 5,382,658
Title: | Stability-enhanced variants of parathyroid hormone |
Abstract: | Herein described are variants of parathyroid hormone that retain significant PTH activity and are substantially resistant to trypsin and trypsin-like enzymes. The variants are useful pharmaceutically, to treat bone disorders such as osteoporosis and in other therapeutic applications. Specific embodiments of the invention include [His.sup.25 ]PTH and [His.sup.25 His.sup.26 Leu.sup.27 ]PTH. |
Inventor(s): | Kronis; K. Anne (Toronto, CA), Bozzato; Richard P. (Etobicoke, CA) |
Assignee: | Allelix Biopharmaceuticals Inc. (Mississauga, CA) Glaxo Canada Inc. (Mississauga, CA) |
Application Number: | 07/863,014 |
Patent Claims: | see list of patent claims |
Details for Patent 5,382,658
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | See Plans and Pricing | 2039-03-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |